43 companies

Johnson & Johnson

Market Cap: US$470.4b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

JNJ

US$195.93

7D

5.0%

1Y

27.2%

Novartis

Market Cap: CHF 200.4b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

NOVN

CHF 104.42

7D

2.4%

1Y

13.9%

Merck

Market Cap: US$230.7b

Operates as a healthcare company worldwide.

MRK

US$92.92

7D

7.7%

1Y

-3.5%

Exelixis

Market Cap: US$11.4b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$41.65

7D

2.1%

1Y

20.9%

Orion Oyj

Market Cap: €8.4b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€60.00

7D

5.5%

1Y

34.5%

Abbott India

Market Cap: ₹621.0b

Operates as a pharmaceutical company in India.

500488

₹29,223.10

7D

1.5%

1Y

6.9%

SK Biopharmaceuticals

Market Cap: ₩10.0t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

A326030

₩128,300.00

7D

10.6%

1Y

24.2%

Shanghai Allist Pharmaceuticals

Market Cap: CN¥46.0b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.

688578

CN¥102.12

7D

1.1%

1Y

99.0%

Zealand Pharma

Market Cap: DKK 36.2b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

ZEAL

DKK 513.60

7D

20.3%

1Y

-28.7%

Tianjin Pharmaceutical Da Ren Tang Group

Market Cap: CN¥32.5b

Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.

600329

CN¥49.50

7D

0.8%

1Y

46.2%

Xiamen Amoytop Biotech

Market Cap: CN¥31.7b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

688278

CN¥77.86

7D

6.5%

1Y

4.3%

ADMA Biologics

Market Cap: US$3.7b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

ADMA

US$15.56

7D

7.2%

1Y

-18.3%

HUTCHMED (China)

Market Cap: UK£2.0b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

HCM

UK£2.28

7D

-3.4%

1Y

-13.6%

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥18.2b

Engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China.

300573

CN¥74.00

7D

-1.7%

1Y

18.4%

Neuren Pharmaceuticals

Market Cap: AU$2.4b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$19.00

7D

2.3%

1Y

13.7%

CureVac

Market Cap: US$1.2b

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

CVAC

US$5.28

7D

1.3%

1Y

107.9%

Sanofi India

Market Cap: ₹105.6b

Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.

500674

₹4,584.50

7D

-1.2%

1Y

-25.8%

Procter & Gamble Health

Market Cap: ₹97.7b

Manufactures and markets pharmaceuticals and chemical products in India and internationally.

500126

₹5,886.95

7D

0.9%

1Y

14.4%

Philogen

Market Cap: €942.2m

A biotechnology company, develops drugs for oncology and chronic inflammatory diseases in Switzerland and the European Union.

PHIL

€23.40

7D

-1.7%

1Y

17.0%

CorMedix

Market Cap: US$883.2m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

New

CRMD

US$11.24

7D

4.5%

1Y

8.8%

L&C BIOLTD

Market Cap: ₩1.2t

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.

A290650

₩50,400.00

7D

-0.8%

1Y

215.0%

Sunmax Biotechnology

Market Cap: NT$21.5b

A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.

New

4728

NT$394.50

7D

0.9%

1Y

44.2%

Ever Supreme Bio Technology

Market Cap: NT$14.5b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.

6712

NT$165.00

7D

3.4%

1Y

4.0%

GlaxoSmithKline Pakistan

Market Cap: PK₨125.4b

Operates as a biopharma company in Pakistan.

GLAXO

PK₨393.75

7D

-1.2%

1Y

29.8%

SIGA Technologies

Market Cap: US$435.4m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

SIGA

US$6.00

7D

-8.3%

1Y

1.0%

RPG Life Sciences

Market Cap: ₹37.9b

An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.

RPGLIFE

₹2,293.30

7D

-4.5%

1Y

6.3%

PharmaEngine

Market Cap: NT$10.3b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

4162

NT$72.00

7D

5.9%

1Y

-27.9%

Puma Biotechnology

Market Cap: US$249.4m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

PBYI

US$4.89

7D

-18.4%

1Y

102.1%

Abeona Therapeutics

Market Cap: US$245.5m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

ABEO

US$4.45

7D

6.0%

1Y

-24.1%

Hoechst Pakistan

Market Cap: PK₨40.4b

Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.

HPL

PK₨4,191.66

7D

2.6%

1Y

60.7%

NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag

Market Cap: Ft35.9b

Manufactures and sells pharmaceutical products in Hungary.

NATURLAND

Ft2,600.00

7D

0%

1Y

8.3%

Alexandria For Pharmaceuticals & Chemical Industries

Market Cap: ج.م4.0b

Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.

AXPH

ج.م806.60

7D

-0.7%

1Y

152.1%

Kahira Pharmaceuticals & Chemical Industries

Market Cap: ج.م4.0b

Engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt.

CPCI

ج.م265.13

7D

-5.0%

1Y

163.9%

2invest

Market Cap: €65.6m

An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.

2INV

€11.90

7D

-6.3%

1Y

13.3%

Winston Medical Supply

Market Cap: NT$2.0b

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.

6817

NT$106.50

7D

-1.8%

1Y

18.7%

Pharmedic Pharmaceutical Medicinal

Market Cap: ₫1.6t

Engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam.

PMC

₫167,000.00

7D

-1.3%

1Y

59.0%

Page 1 of 2